Chiara Greco

Synthesis and Antibacterial Evaluation of New Pyrazolo[3,4-d]pyrimidines Kinase Inhibitors

F. Musumeci, S. Schenone, C. Alexander, 2020, Molecules.

Recent Studies on Ponatinib in Cancers Other Than Chronic Myeloid Leukemia

F. Musumeci, S. Schenone, G. Grossi, 2018, Cancers.

Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors

F. Musumeci, A. L. Fallacara, S. Schenone, 2017, Expert opinion on therapeutic patents.

An Update on JAK Inhibitors.

F. Musumeci, C. Brullo, A. L. Fallacara, 2019, Current medicinal chemistry.

Development of Pyrazolo[3,4-d]pyrimidine Kinase Inhibitors as Potential Clinical Candidates for Glioblastoma Multiforme.

Amanda K. Pearce, F. Musumeci, S. Schenone, 2020, ACS medicinal chemistry letters.

Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines.

F. Musumeci, A. L. Fallacara, E. Crespan, 2019, European journal of medicinal chemistry.

Insights into RNA-dependent RNA Polymerase Inhibitors as Anti-influenza Virus Agents.

F. Musumeci, S. Schenone, G. Grossi, 2020, Current medicinal chemistry.

Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors

F. Musumeci, A. L. Fallacara, S. Schenone, 2017, Expert opinion on therapeutic patents.